Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Woolf

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 29, 2017
Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC-MS/MS to support biosimilar clinical studiesYang Xu, Li Sun, Melanie Anderson, et al.
Journal of Clinical Pharmacology|February 20, 2004
Indinavir and rifabutin drug interactions in healthy volunteersWalter K Kraft, Jacqueline B McCrea, Gregory A Winchell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2003
Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteersA David Rodrigues, Rita A Halpin, Leslie A Geer, et al.
Bioanalysis|December 17, 2014
A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocritNeil Spooner, Philip Denniff, Luc Michielsen, et al.
Journal of Clinical Pharmacology|October 1, 2003
Pharmacokinetics of etoricoxib in patients with hepatic impairmentNancy G B Agrawal, Mark J Rose, Catherine Z Matthews, et al.
Clinical and Translational Science|March 26, 2018
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of ErtugliflozinSangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe, et al.
Journal of Clinical Pharmacology|March 18, 2003
Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in manNancy G B Agrawal, Arturo G Porras, Catherine Z Matthews, et al.
Journal of Clinical Pharmacology|September 3, 2004
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activityNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.
Journal of Clinical Pharmacology|December 19, 2003
Pharmacokinetics of etoricoxib in patients with renal impairmentNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.
The AAPS Journal|June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamsEric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 29, 2017
Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC-MS/MS to support biosimilar clinical studiesYang Xu, Li Sun, Melanie Anderson, et al.
Journal of Clinical Pharmacology|February 20, 2004
Indinavir and rifabutin drug interactions in healthy volunteersWalter K Kraft, Jacqueline B McCrea, Gregory A Winchell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2003
Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteersA David Rodrigues, Rita A Halpin, Leslie A Geer, et al.
Bioanalysis|December 17, 2014
A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocritNeil Spooner, Philip Denniff, Luc Michielsen, et al.
Journal of Clinical Pharmacology|October 1, 2003
Pharmacokinetics of etoricoxib in patients with hepatic impairmentNancy G B Agrawal, Mark J Rose, Catherine Z Matthews, et al.
Clinical and Translational Science|March 26, 2018
Novel Application of the Two-Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of ErtugliflozinSangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe, et al.
Journal of Clinical Pharmacology|March 18, 2003
Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in manNancy G B Agrawal, Arturo G Porras, Catherine Z Matthews, et al.
Journal of Clinical Pharmacology|September 3, 2004
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activityNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.
Journal of Clinical Pharmacology|December 19, 2003
Pharmacokinetics of etoricoxib in patients with renal impairmentNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.
The AAPS Journal|June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamsEric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Pageof 3